MAPT and Alzheimer disease: Therefore, maintenance of CDK5 homeostasis is suggested as a reasonable therapeutic target for ameliorating AD pathological processes, such as neuronal apoptosis and tau pathology (Sun et al., 2008; Lopes et al., 2010; Piedrahita et al., 2010).